BRPI0916432A2 - compostos - Google Patents

compostos

Info

Publication number: BRPI0916432A2
Authority: BR; Brazil
Prior art keywords: compounds
Prior art date: 2008-07-29

Application number

BRPI0916432A

Other languages

English (en)

Inventor

Matthias Treu

Thomas Karner

Ulrich Reiser

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-29

Filing date

2009-07-28

Publication date

2016-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951549&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0916432(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-07-28 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2016-02-16 Publication of BRPI0916432A2 publication Critical patent/BRPI0916432A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

BRPI0916432A 2008-07-29 2009-07-28 compostos BRPI0916432A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08161381		2008-07-29
PCT/EP2009/059770 WO2010012747A1 (en)	2008-07-29	2009-07-28	New compounds

Publications (1)

Publication Number	Publication Date
BRPI0916432A2 true BRPI0916432A2 (pt)	2016-02-16

Family

ID=39951549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0916432A BRPI0916432A2 (pt)	2008-07-29	2009-07-28	compostos

Country Status (22)

Country	Link
US (1)	US8853420B2 (pt)
EP (2)	EP2324012A1 (pt)
JP (1)	JP5651110B2 (pt)
KR (1)	KR20110039474A (pt)
CN (1)	CN102112468A (pt)
AR (1)	AR072538A1 (pt)
AU (1)	AU2009275964A1 (pt)
BR (1)	BRPI0916432A2 (pt)
CA (1)	CA2731919A1 (pt)
CL (1)	CL2011000165A1 (pt)
CO (1)	CO6331434A2 (pt)
EA (1)	EA201100254A1 (pt)
EC (1)	ECSP11010816A (pt)
IL (1)	IL210344A0 (pt)
MA (1)	MA32506B1 (pt)
MX (1)	MX2011000730A (pt)
NZ (1)	NZ590560A (pt)
PE (1)	PE20110213A1 (pt)
SG (1)	SG193154A1 (pt)
TW (1)	TW201011002A (pt)
UY (1)	UY32010A (pt)
WO (1)	WO2010012747A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120107304A1 (en)	2010-04-27	2012-05-03	Boehringer Ingelheim International Gmbh	Combination therapy in treatment of oncological and fibrotic diseases
US20130004481A1 (en) *	2011-01-12	2013-01-03	Boehringer Ingelheim International Gmbh	Anticancer therapy
US20130122005A1 (en)	2011-10-27	2013-05-16	Paul Adam	Anticancer combination therapy
CN103130775B (zh) *	2011-11-22	2015-09-30	山东亨利医药科技有限责任公司	作为酪氨酸激酶抑制剂的吲哚满酮衍生物
WO2013119774A1 (en) *	2012-02-10	2013-08-15	Virginia Commonwealth University	3-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitors
WO2014009318A1 (en)	2012-07-11	2014-01-16	Boehringer Ingelheim International Gmbh	3-{3-[1 -(4-dimethylaminomethyl-phenylamino)-1 -phenyl-meth-(z)-ylidene]-2-oxo-2,3-dihydro-1 h-indol-6-yll-propynoic acid ethylamide and its use in the treatment of cancer
WO2014009319A1 (en)	2012-07-11	2014-01-16	Boehringer Ingelheim International Gmbh	Indolinone derivatives anticancer compounds
TWI644899B (zh)	2013-02-04	2018-12-21	健生藥品公司	Ｆｌａｐ調節劑
US9745328B2 (en)	2013-02-04	2017-08-29	Janssen Pharmaceutica Nv	Flap modulators
SG11201507346PA (en) *	2013-03-13	2015-10-29	Boston Biomedical Inc	3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000018734A1 (de)	1998-09-25	2000-04-06	Boehringer Ingelheim Pharma Kg	Neue substituierte indolinone mit inhibierender wirkung auf verschiedene kinasen und cyclin/cdk-komplexe
DE19924401A1 (de)	1999-05-27	2000-11-30	Boehringer Ingelheim Pharma	Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
EP1212318B1 (de)	1999-08-27	2006-01-25	Boehringer Ingelheim Pharma GmbH & Co.KG	Substituierte indolinone als tyrosinkinase inhibitoren
UA75054C2 (uk) *	1999-10-13	2006-03-15	Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг	Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
US6762180B1 (en)	1999-10-13	2004-07-13	Boehringer Ingelheim Pharma Kg	Substituted indolines which inhibit receptor tyrosine kinases
DE10117204A1 (de)	2001-04-06	2002-10-10	Boehringer Ingelheim Pharma	In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
PE20040701A1 (es)	2002-07-23	2004-11-30	Boehringer Ingelheim Pharma	Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
US7169936B2 (en)	2002-07-23	2007-01-30	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US7148249B2 (en)	2002-09-12	2006-12-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
US20050043233A1 (en) *	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
US20060154939A1 (en) *	2004-12-24	2006-07-13	Boehringer Ingelheim International Gmbh	Medicaments for the Treatment or Prevention of Fibrotic Diseases
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2007057397A1 (en) *	2005-11-15	2007-05-24	Boehringer Ingelheim International Gmbh	Treatment of cancer
CA2646638A1 (en)	2006-04-24	2007-11-01	Boehringer Ingelheim International Gmbh	3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
EP1870400A1 (en)	2006-06-08	2007-12-26	Boehringer Ingelheim Pharma GmbH & Co. KG	Salts and crystalline salt forms of an 2-indolinone derivative
UY31984A (es) *	2008-07-16	2010-02-26	Boehringer Ingelheim Int	DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas.
UY31982A (es)	2008-07-16	2010-02-26	Boehringer Ingelheim Int	Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
EP2321290B1 (en)	2008-07-29	2012-06-20	Amgen, Inc	Asymmetric process for making substituted 2-amino-thiazolones
PE20110196A1 (es)	2008-07-29	2011-04-03	Boehringer Ingelheim Int	5-alquinil-pirimidinas

2009
- 2009-07-28 US US13/125,841 patent/US8853420B2/en active Active
- 2009-07-28 PE PE2011000099A patent/PE20110213A1/es not_active Application Discontinuation
- 2009-07-28 AR ARP090102874A patent/AR072538A1/es unknown
- 2009-07-28 MX MX2011000730A patent/MX2011000730A/es not_active Application Discontinuation
- 2009-07-28 TW TW098125418A patent/TW201011002A/zh unknown
- 2009-07-28 UY UY0001032010A patent/UY32010A/es not_active Application Discontinuation
- 2009-07-28 CA CA2731919A patent/CA2731919A1/en not_active Abandoned
- 2009-07-28 NZ NZ590560A patent/NZ590560A/xx not_active IP Right Cessation
- 2009-07-28 EP EP09802511A patent/EP2324012A1/en not_active Withdrawn
- 2009-07-28 BR BRPI0916432A patent/BRPI0916432A2/pt not_active IP Right Cessation
- 2009-07-28 CN CN2009801301747A patent/CN102112468A/zh active Pending
- 2009-07-28 EP EP12160987A patent/EP2471787A1/en not_active Ceased
- 2009-07-28 KR KR1020117004476A patent/KR20110039474A/ko not_active Application Discontinuation
- 2009-07-28 JP JP2011520494A patent/JP5651110B2/ja not_active Expired - Fee Related
- 2009-07-28 SG SG2013057252A patent/SG193154A1/en unknown
- 2009-07-28 AU AU2009275964A patent/AU2009275964A1/en not_active Abandoned
- 2009-07-28 EA EA201100254A patent/EA201100254A1/ru unknown
- 2009-07-28 WO PCT/EP2009/059770 patent/WO2010012747A1/en active Application Filing
2010
- 2010-12-29 IL IL210344A patent/IL210344A0/en unknown
2011
- 2011-01-26 MA MA33561A patent/MA32506B1/fr unknown
- 2011-01-26 CL CL2011000165A patent/CL2011000165A1/es unknown
- 2011-01-27 CO CO11009250A patent/CO6331434A2/es active IP Right Grant
- 2011-02-09 EC EC2011010816A patent/ECSP11010816A/es unknown

Also Published As

Publication number	Publication date
CO6331434A2 (es)	2011-10-20
EP2324012A1 (en)	2011-05-25
IL210344A0 (en)	2011-03-31
SG193154A1 (en)	2013-09-30
ECSP11010816A (es)	2011-03-31
MA32506B1 (fr)	2011-07-03
TW201011002A (en)	2010-03-16
US20110263565A1 (en)	2011-10-27
US8853420B2 (en)	2014-10-07
AU2009275964A1 (en)	2010-02-04
MX2011000730A (es)	2011-03-15
WO2010012747A1 (en)	2010-02-04
JP5651110B2 (ja)	2015-01-07
EA201100254A1 (ru)	2011-08-30
CN102112468A (zh)	2011-06-29
CL2011000165A1 (es)	2011-06-17
KR20110039474A (ko)	2011-04-18
UY32010A (es)	2010-02-26
NZ590560A (en)	2012-12-21
PE20110213A1 (es)	2011-04-16
EP2471787A1 (en)	2012-07-04
CA2731919A1 (en)	2010-02-04
AR072538A1 (es)	2010-09-01
JP2011529470A (ja)	2011-12-08

Legal Events

Date	Code	Title	Description
2016-06-21	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-10-11	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
SMT201600045B (it)	2016-02-25	Composti tetraciclinici c7-fluoro sostituiti
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
DK2342317T3 (da)	2013-03-18	Hængende-dråbe-plade
DE602009000234D1 (de)	2010-11-11	msignals
BRPI0914649A2 (pt)	2015-07-07	Piprazolo-quinazolinas
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DE602008003521D1 (de)	2010-12-30	Sitzrücklehnungsmechanismus
DK2336132T3 (da)	2014-04-07	Morpholinpurinderivat
DK2297162T3 (da)	2012-11-26	Forbindelser
DK2335031T3 (da)	2019-08-26	In-line-måler
DE602008003970D1 (de)	2011-01-27	Strahlstromkalibriersystem
DK2271613T3 (da)	2014-07-14	Hydroxymethylcyklohexylaminer
BRPI0916432A2 (pt)	2016-02-16	compostos
BRPI0923592A2 (pt)	2016-01-26	composto
DE112009001946A5 (de)	2011-07-14	Mobelauszugsführung
DE602009000488D1 (de)	2011-02-10	Obstvereinzelvorrichtung
BRPI0911393A2 (pt)	2015-12-29	composto de 5-hidroxipirimidina-4-carboxamida
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
BRPI0909637A2 (pt)	2015-09-22	2-aminoquinolinas
DE602009000862D1 (de)	2011-04-28	Gehwagenbremse
AT507449A3 (de)	2010-11-15	Dämmstoffbefestiger